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FIG. S2. Electroporation optimization. A)
Fibroblasts were electroporated with the GFP expressing plasmid pmax to evaluate the efficiency and viability. 15 different programs were tested and compared to a non-electroporated sample. B) RNP complexes targeting B2M exon 1 were delivered to the cells in presence or absence of an electroporation enhancer using programs CA137, CM137 and CM138. Cells were left in culture for 24 hours and then collected for MiSeq genotyping to measure editing efficiencies. Program CM138 was selected for following genome editing experiments.
Cells were electroporated with RNPs targeting SMAD2 exon 6, SMAD3 exon 2, SMAD3 exon 4, SMAD3 exon 6 and the double targeting for SMAD3 exon 6/SMAD2 exon 6 together. Cells were also electroporated with a RNP carrying a scrambled crRNA as a negative control. One week after the electroporation, cells were assayed in the Scar-in-a-Jar assay for collagen type I deposition and αSMA staining. figure 4B . Western blot analysis from wild type, SMAD2 KO, SMAD3 KO and double KO cells. One antibody recognising both SMAD proteins was used, because the two proteins share more than 90% homology of amino acid sequence. ACTIN was the loading control. Step 1-Cell preparation
FIG. S5. Unprocessed western blot from
• 1 million human primary lung fibroblasts derived from IPF patients, passage 2, were thawed at 37˚C, in a water bath, for 2 minutes, until a small chip of ice was visible.
• Cells were then transferred to a 15 ml falcon tube with 10 ml of growth media, to dilute the DMSO.
• The 15 ml falcon tube was then spun down at 1,100rpm, for 5 minutes, at room temperature.
• The supernatant was discarded, and the pellet was resuspended in 10 ml of growth media.
• Cells were then transferred to a T175cm 2 flask previously filled with 20 ml of growth media.
• Cells were incubated overnight in a 37˚C incubator with 10% CO2.
• On the day after, growth media was changed to get rid any dead cells (caused by the thawing) and cells were left growing for another two days.
• When cells reached around 80% confluency, they were considered ready to be electroporated.
Step 2-RNP formation
• 1 µl from Alt-R® CRISPR-Cas9 crRNA (100 µM) and Alt-R® CRISPR-Cas9 tracrRNA (100 µM)
were mixed together and diluted in nuclease-free duplex buffer to achieve a concentration of 25 µM.
• The RNA mix was boiled at 95˚C for 5 minutes and cooled down at room temperature for 7
• 2.9 µl of the annealed RNA, corresponding to 72.5 pmol, were complexed with 1 µl of Cas9 (60 pmol/µl) to a ratio of 1.2:1.
• This mix was left at room temperature for 10 minutes.
• 0.6 µl of electroporator enhancer (100µM; IDT) were added and incubated at room temperature with the RNP complex for 5 minutes.
Step 3-Cell electroporation
• Pre-warm an empty cell culture plate with growth media to equilibrate the plate.
• Approximately 80% confluent lung fibroblasts were washed once with 15 ml of PBS Ca-/Mg-.
• PBS Ca-/Mg-was removed from the flask and 10 ml of TrypLE were added. The flask was returned for 5 minutes at 37 ˚C in the incubator to obtain cell detachment.
• Once cells were floating, detachment reaction was stopped by diluting TrypLE with 10 ml of growth media.
• Cells were then spun down at 1,100 rpm, the pellet was then resuspended in 10 ml of PBS Ca-/Mg-.
• 0.5 ml of cell suspension was used to count cells using the Vi-CELL XR cell counter (Beckman Coulter).
• 250,000 cells were used per electroporation. Cells were spun down at 90g, for 10 minutes, at room temperature.
• After PBS removal, cells were resuspended in 15.5 µl of P3 solution from a P3 Primary Cell 4D-Nucleofector® X Kit (Lonza) and mixed together with 4.5 µl of RNP complex to reach a total volume of 20 µl. Important: Cells cannot be left in the P3 solution for more than 10 minutes, otherwise viability will be affected.
• Electroporation was performed in 16-well Nucleocuvette™ Strips, using program CM-138 of 4D Nucleofector System (Lonza).
• 100 µl of growth media using a p200 pipette was added on top of the cells in the 16 well strip. Note: Cells are transferred immediately to the pre-warmed cell culture plate, even though Lonza recommends to leave cells resting in the strip for 10 minutes. We found no benefit in implementing this step.
• Cell were then transferred to the pre-warmed cell culture plate and left 24 hours before being analysed by MiSeq sequencing (according to the protocol described by SchmidBurgk JL et al. 2014) .
Important: For a double KO generation, 4.5 µl of RNP targeting SMAD2 exon 6 and 4.5 µl of RNP targeting SMAD3 exon 6 were complexed in vitro as described above. 250,000 cells were spun down, at 90g, for 10 minutes, at room temperature. After PBS removal, cells were re-suspended in 11 µl of P3 solution and mixed together with 9 µl of RNPs targeting SMAD2 and SMAD3 to reach a final volume of 20 µl. Electroporation was performed in 16-well Nucleocuvette™ Strips, using program CM-138. 
